Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
Lyrica 25 mg hard capsules.
Lyrica 50 mg hard capsules.
Lyrica 75 mg hard capsules.
Lyrica 100 mg hard capsules.
Lyrica 150 mg hard capsules.
Lyrica 200 mg hard capsules.
Lyrica 225 mg hard capsules.
Lyrica 300 mg hard capsules.
Pharmaceutical Form |
---|
Hard capsules. Lyrica 25 mg hard capsules: White marked “Pfizer” on the cap and “PGN 25” on the body with black ink. Lyrica 50 mg hard capsules: White marked “Pfizer” on the cap and “PGN 50” on the body with black ink. The body is also marked with a black band. Lyrica 75 mg hard capsules: White and orange, marked “Pfizer” on the cap and “PGN 75” on the body with black ink. Lyrica 100 mg hard capsules: Orange marked “Pfizer” on the cap and “PGN 100” on the body with black ink. Lyrica 150 mg hard capsules: White marked “Pfizer” on the cap and “PGN 150” on the body with black ink. Lyrica 200 mg hard capsules: Light orange, marked “Pfizer” on the cap and “PGN 200” on the body with black ink. Lyrica 225 mg hard capsules: White and light orange marked “Pfizer” on the cap and “PGN 225” on the body with black ink. Lyrica 300 mg hard capsules: White and orange, marked “Pfizer” on the cap and “PGN 300” on the body with black ink. |
Lyrica 25 mg hard capsules: Each hard capsule contains 25 mg of pregabalin.
Lyrica 50 mg hard capsules: Each hard capsule contains 50 mg of pregabalin.
Lyrica 75 mg hard capsules: Each hard capsule contains 75 mg of pregabalin.
Lyrica 100 mg hard capsules: Each hard capsule contains 100 mg of pregabalin.
Lyrica 150 mg hard capsules: Each hard capsule contains 150 mg of pregabalin.
Lyrica 200 mg hard capsules: Each hard capsule contains 200 mg of pregabalin.
Lyrica 225 mg hard capsules: Each hard capsule contains 225 mg of pregabalin.
Lyrica 300 mg hard capsules: Each hard capsule contains 300 mg of pregabalin.
Excipients with known effect:
Lyrica 25 mg hard capsules: Each hard capsule also contains 35 mg lactose monohydrate.
Lyrica 50 mg hard capsules: Each hard capsule also contains 70 mg lactose monohydrate.
Lyrica 75 mg hard capsules: Each hard capsule also contains 8.25 mg lactose monohydrate.
Lyrica 100 mg hard capsules: Each hard capsule also contains 11 mg lactose monohydrate.
Lyrica 150 mg hard capsules: Each hard capsule also contains 16.50 mg lactose monohydrate.
Lyrica 200 mg hard capsules: Each hard capsule also contains 22 mg lactose monohydrate.
Lyrica 225 mg hard capsules: Each hard capsule also contains 24.75 mg lactose monohydrate.
Lyrica 300 mg hard capsules: Each hard capsule also contains 33 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Pregabalin |
Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system. |
List of Excipients |
---|
Lyrica 25 mg, 50 mg, 150 mg hard capsulesCapsules content: Lactose monohydrate Capsules shell: Gelatin Printing ink: Shellac Lyrica 75 mg, 100 mg, 200 mg, 225 mg, 300 mg hard capsulesCapsules content: Lactose monohydrate Capsules shell: Gelatin Printing ink: Shellac |
Lyrica 25 mg hard capsules: PVC/Aluminium blisters containing 14, 21, 56, 84, 100 or 112 (2 × 56) hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters. HDPE bottle containing 200 hard capsules.
Not all pack sizes may be marketed.
Lyrica 50 mg hard capsules: PVC/Aluminium blisters containing 14, 21, 56, 84, or 100 hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters.
Not all pack sizes may be marketed.
Lyrica 75 mg hard capsules: PVC/Aluminium blisters containing 14, 56, 70 100, or 112 (2 × 56) hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters. HDPE bottle containing 200 hard capsules.
Not all pack sizes may be marketed.
Lyrica 100 mg hard capsules: PVC/Aluminium blisters containing 21, 84, or 100 hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters.
Not all pack sizes may be marketed.
Lyrica 150 mg hard capsules: PVC/Aluminium blisters containing 14, 56, 100, or 112 (2 × 56) hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters. HDPE bottle containing 200 hard capsules.
Not all pack sizes may be marketed.
Lyrica 200 mg hard capsules: PVC/Aluminium blisters containing 21, 84, or 100 hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters.
Not all pack sizes may be marketed.
Lyrica 225 mg hard capsules: PVC/Aluminium blisters containing 14, 56, or 100 hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters.
Not all pack sizes may be marketed.
Lyrica 300 mg hard capsules: PVC/Aluminium blisters containing 14, 56, 100, or 112 (2 × 56) hard capsules. 100 × 1 hard capsules in PVC/Aluminium perforated unit dose blisters. HDPE bottle containing 200 hard capsules.
Not all pack sizes may be marketed.
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
Lyrica 25 mg hard capsules:
EU/1/04/279/001-005
EU/1/04/279/026
EU/1/04/279/036
EU/1/04/279/046
Lyrica 50 mg hard capsules:
EU/1/04/279/006-010
EU/1/04/279/037
Lyrica 75 mg hard capsules:
EU/1/04/279/011-013
EU/1/04/279/027
EU/1/04/279/030
EU/1/04/279/038
EU/1/04/279/045
Lyrica 100 mg hard capsules:
EU/1/04/279/014-016
EU/1/04/279/39
Lyrica 150 mg hard capsules:
EU/1/04/279/017-019
EU/1/04/279/028
EU/1/04/279/031
EU/1/04/279/040
Lyrica 200 mg hard capsules:
EU/1/04/279/020–022
EU/1/04/279/041
Lyrica 225 mg hard capsules:
EU/1/04/279/033–035
EU/1/04/279/042
Lyrica 300 mg hard capsules:
EU/1/04/279/023–025
EU/1/04/279/029
EU/1/04/279/032
EU/1/04/279/043
Date of first authorisation: 06 July 2004
Date of last renewal: 06 July 2009
Drug | Countries | |
---|---|---|
LYRICA | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.